Developer docs
API playgroundTry for free, no card

Search company profiles

Prime Diagnostics

Full company profile

uuid0031z5y

Namestring
Prime Diagnostics
Legal namestring
PRIME DIAGNOSTICS
Websiteurl
primedx.us
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Prime Diagnostics is a Valdosta, Georgia-based high-complexity clinical diagnostics laboratory founded in 2021 that specializes in molecular pathogen testing using Real-Time PCR (RT-PCR) technology. The company operates two accredited laboratories — a headquarters facility in Valdosta, GA and a second site in Lake City, FL — both holding CLIA, COLA, and CAP accreditations plus HIPAA-compliant patient result handling. Its product portfolio centers on seven proprietary multi-pathogen RT-PCR panels (UTI-PDx, UTI-STI-PDx, Respira-PDx, Gastro-PDx, Abx-PDx, Wound-PDx, and Nail-PDx) designed to detect multiple infectious agents from a single patient sample, complemented by a comprehensive blood testing service covering hematology, chemistry, immunology, microbiology, and additional molecular panels, all delivered with a 24-48 hour turnaround time.

The company's go-to-market is a B2B clinical laboratory services model targeting healthcare providers — physicians, clinics, hospitals, and medical practices — primarily in Georgia and Florida. Specimen logistics rely on overnight shipping into the two lab locations, with ordering and results delivered through a dedicated Provider Portal (portal.primedx.us) and account management via a Sales Portal (prime.dxresults.com). Revenue is generated on a transaction basis through in-network insurance reimbursement, with a cash-pay billing option for uninsured patients processed through a third-party billing platform (InboxHealth). The Phlebotomy services capability extends sample collection directly to provider locations, supporting workflow integration.

The company is privately held with no disclosed funding rounds, parent company, or management team details in available sources. Strategic positioning emphasizes rapid turnaround, comprehensive single-facility testing (reducing need for multiple lab referrals), and proprietary resistance-marker detection (Abx-PDx covers 20+ AMR targets) intended to support antibiotic stewardship programs. The current evidence base — two regional labs, a defined but un-disclosed provider customer base, and no public revenue figures — indicates an early-stage operational footprint with directional expansion signals but insufficient quantitative disclosure to assess scale.

Short descriptiontext

Prime Diagnostics is a privately held, Valdosta, Georgia-based high-complexity clinical diagnostics laboratory operating two CLIA/COLA/CAP-accredited sites in Georgia and Florida. It serves healthcare providers with proprietary Real-Time PCR multi-pathogen panels and comprehensive blood testing delivered with 24-48 hour turnaround.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersValdosta, United States
HQ citystring
Valdosta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical diagnostics, molecular diagnostics, RT-PCR testing, pathogen detection, clinical laboratory services
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Diagnostic Laboratory Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Laboratory Diagnostic Testing Services
TypeTransaction Fee
Description

Clinical laboratory testing services billed to insurance providers (in-network payer mix) or directly to patients. Services include molecular diagnostics (RT-PCR), blood testing, and various pathogen panels. The company offers cash billing options for uninsured patients with transparent pricing.

primedx.us
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales
Pricing details1 tier
1Insurance-billed testing
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Services billed to insurance providers where Prime Diagnostics is in-network. Patient responsibility varies based on deductibles, copays, and coverage.

primedx.us
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Prime Diagnostics is a high-complexity clinical diagnostics laboratory that provides molecular (RT-PCR) pathogen testing and blood testing services to healthcare providers. Its test menu includes UTI, UTI-STI, Respiratory, Gastrointestinal, Wound, Nail, and Antibiotic Stewardship (Abx-PDx) panels, alongside comprehensive hematology and chemistry panels. Samples are processed at its CLIA/COLA/CAP-accredited labs in Georgia and Florida with a 24-48 hour turnaround.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 24-48 hour turnaround time from sample receipt to results delivery
+2 more records
Product overview1 text field

Prime Diagnostics is a high-complexity clinical laboratory offering a unified diagnostic testing platform centered on Real-Time PCR technology. The portfolio comprises named diagnostic test panels including UTI-PDx, UTI-STI-PDx, Respira-PDx, Gastro-PDx, Abx-PDx, Wound-PDx, and Nail-PDx—all powered by real-time PCR for simultaneous multi-pathogen detection from single samples. Supporting these molecular tests is a comprehensive blood testing service covering hematology, chemistry, immunology, and infectious disease panels. All tests are processed at the company's CLIA-certified laboratories in Georgia and Florida with a 24-48 hour turnaround time.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Prime Diagnostics

Clinical Diagnostic Laboratory Servicesprimedx.us

Prime Diagnostics is a privately held, Valdosta, Georgia-based high-complexity clinical diagnostics laboratory operating two CLIA/COLA/CAP-accredited sites in Georgia and Florida. It serves healthcare providers with proprietary Real-Time PCR multi-pathogen panels and comprehensive blood testing delivered with 24-48 hour turnaround.

What Prime Diagnostics does

Prime Diagnostics is a Valdosta, Georgia-based high-complexity clinical diagnostics laboratory founded in 2021 that specializes in molecular pathogen testing using Real-Time PCR (RT-PCR) technology. The company operates two accredited laboratories — a headquarters facility in Valdosta, GA and a second site in Lake City, FL — both holding CLIA, COLA, and CAP accreditations plus HIPAA-compliant patient result handling. Its product portfolio centers on seven proprietary multi-pathogen RT-PCR panels (UTI-PDx, UTI-STI-PDx, Respira-PDx, Gastro-PDx, Abx-PDx, Wound-PDx, and Nail-PDx) designed to detect multiple infectious agents from a single patient sample, complemented by a comprehensive blood testing service covering hematology, chemistry, immunology, microbiology, and additional molecular panels, all delivered with a 24-48 hour turnaround time.

The company's go-to-market is a B2B clinical laboratory services model targeting healthcare providers — physicians, clinics, hospitals, and medical practices — primarily in Georgia and Florida. Specimen logistics rely on overnight shipping into the two lab locations, with ordering and results delivered through a dedicated Provider Portal (portal.primedx.us) and account management via a Sales Portal (prime.dxresults.com). Revenue is generated on a transaction basis through in-network insurance reimbursement, with a cash-pay billing option for uninsured patients processed through a third-party billing platform (InboxHealth). The Phlebotomy services capability extends sample collection directly to provider locations, supporting workflow integration.

The company is privately held with no disclosed funding rounds, parent company, or management team details in available sources. Strategic positioning emphasizes rapid turnaround, comprehensive single-facility testing (reducing need for multiple lab referrals), and proprietary resistance-marker detection (Abx-PDx covers 20+ AMR targets) intended to support antibiotic stewardship programs. The current evidence base — two regional labs, a defined but un-disclosed provider customer base, and no public revenue figures — indicates an early-stage operational footprint with directional expansion signals but insufficient quantitative disclosure to assess scale.

Prime Diagnostics firmographics

Firmographics
Name
Prime Diagnostics
Legal name
PRIME DIAGNOSTICS
Website
https://primedx.us
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Prime Diagnostics is a privately held, Valdosta, Georgia-based high-complexity clinical diagnostics laboratory operating two CLIA/COLA/CAP-accredited sites in Georgia and Florida. It serves healthcare providers with proprietary Real-Time PCR multi-pathogen panels and comprehensive blood testing delivered with 24-48 hour turnaround.
Ownership category
akta.pro rank

Where Prime Diagnostics is headquartered

Location

Headquarters

HQ city
Valdosta
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Prime Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Laboratory Diagnostic Testing Services: Clinical laboratory testing services billed to insurance providers (in-network payer mix) or directly to patients. Services include molecular diagnostics (RT-PCR), blood testing, and various pathogen panels. The company offers cash billing options for uninsured patients with transparent pricing.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goInsurance-billed testing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Prime Diagnostics product offering

Product offering

Core offering

Prime Diagnostics is a high-complexity clinical diagnostics laboratory that provides molecular (RT-PCR) pathogen testing and blood testing services to healthcare providers. Its test menu includes UTI, UTI-STI, Respiratory, Gastrointestinal, Wound, Nail, and Antibiotic Stewardship (Abx-PDx) panels, alongside comprehensive hematology and chemistry panels. Samples are processed at its CLIA/COLA/CAP-accredited labs in Georgia and Florida with a 24-48 hour turnaround.

Product overview

Prime Diagnostics is a high-complexity clinical laboratory offering a unified diagnostic testing platform centered on Real-Time PCR technology. The portfolio comprises named diagnostic test panels including UTI-PDx, UTI-STI-PDx, Respira-PDx, Gastro-PDx, Abx-PDx, Wound-PDx, and Nail-PDx—all powered by real-time PCR for simultaneous multi-pathogen detection from single samples. Supporting these molecular tests is a comprehensive blood testing service covering hematology, chemistry, immunology, and infectious disease panels. All tests are processed at the company's CLIA-certified laboratories in Georgia and Florida with a 24-48 hour turnaround time.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 24-48 hour turnaround time from sample receipt to results delivery
  • +2 more outcomes

Companies that use Prime Diagnostics

Customer profile

Segments2 records

Ideal customer profiles1 record

Prime Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Prime Diagnostics partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Prime Diagnostics competitors and assessment

Company assessment

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Customer concentration

Prime Diagnostics social profiles

Digital presence

Prime Diagnostics compliance and trust

Trust signal

Compliance4 records

Prime Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Prime Diagnostics leadership team

Management profile

Number of profiles

Prime Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Prime Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prime Diagnostics

What does Prime Diagnostics do?

Prime Diagnostics is a high-complexity clinical diagnostics laboratory that provides molecular (RT-PCR) pathogen testing and blood testing services to healthcare providers. Its test menu includes UTI, UTI-STI, Respiratory, Gastrointestinal, Wound, Nail, and Antibiotic Stewardship (Abx-PDx) panels, alongside comprehensive hematology and chemistry panels. Samples are processed at its CLIA/COLA/CAP-accredited labs in Georgia and Florida with a 24-48 hour turnaround.

Is Prime Diagnostics a public or private company?

Prime Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Prime Diagnostics founded?

Prime Diagnostics was founded in 2021. It employs 11 to 50 people.

Where is Prime Diagnostics based?

Prime Diagnostics is headquartered in Valdosta, United States, in the North America region.

How does Prime Diagnostics make money?

One revenue line is on record: laboratory Diagnostic Testing Services.

Does Prime Diagnostics have an API?

No public API is recorded for Prime Diagnostics.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales